Nurse Charged in Counterfeit Ozempic Scheme

A registered nurse from Chicago, Sharon Charitine Sackman, has been charged in federal court for allegedly distributing counterfeit versions of Ozempic. During 2023, Sackman is accused of providing three individuals with injections falsely presented as the popular diabetes and weight-loss drug. Authorities contend these counterfeit products were not manufactured by the drug's official maker and crucially lacked semaglutide, the active ingredient.

Exploiting the high demand for Ozempic, driven partly by its off-label use for weight loss, Sackman allegedly operated without legal authority to prescribe, dispense, or sell the medication. Court documents reveal she was a registered nurse but lacked the necessary license for these actions. The distribution of these fraudulent drugs poses significant health risks to unsuspecting patients.

Sackman, now residing in Playa del Carmen, Mexico, has pleaded not guilty to charges including distributing misbranded and counterfeit drugs. Each count carries a potential one-year prison sentence. A further court hearing is scheduled for February 3. This case highlights the dangers associated with the unregulated market for weight-loss medications.